Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message| ()  

Here we report a list of healthcare stocks that have been battered lately by the market, but they may also be opportunities to buy in.

We ran a screen on stocks in the healthcare sector for those that are technically oversold, with RSI(14) below 40. We then screened for those stocks that also appear undervalued to earnings growth, with PEG below 1.

?Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the top six stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.?

We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Do you think these stocks will soon make a comeback? Use this list as a starting-off point for your own analysis.

List sorted by market cap.

1. Express Scripts Inc. (ESRX): Provides a range of pharmacy benefit management (PBM) services in North America. Market cap of $22.14B. PEG at 0.95. RSI(14) at 38.48. The stock is a short squeeze candidate, with a short float at 12.5% (equivalent to 6.83 days of average volume). The stock has gained 2.86% over the last year.

2. HCA Inc. (HCA): Offers health care services in the United States. Market cap of $9.65B. PEG at 0.71. RSI(14) at 31.1. The stock is currently stuck in a downtrend, trading 6.71% below its SMA20, 29.99% below its SMA50, and 39.61% below its SMA200.

3. Universal Health Services Inc. (UHS): Operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. Market cap of $3.79B. PEG at 0.98. RSI(14) at 39.62. The stock has gained 16.45% over the last year.

4. United Therapeutics Corp. (UTHR): Engages in the development and commercialization of therapeutic products for patients with chronic and life-threatening diseases in the United States and Internationally. Market cap of $2.43B. PEG at 0.32. RSI(14) at 34.72. The stock is currently stuck in a downtrend, trading 9.65% below its SMA20, 18.73% below its SMA50, and 31.94% below its SMA200. The stock has performed poorly over the last month, losing 18.43%.

5. AMERIGROUP Corporation (AGP): Operates as a multi-state managed healthcare company. Market cap of $2.35B. PEG at 0.69. RSI(14) at 39.3. The stock has gained 25.36% over the last year.

6. Lincare Holdings Inc. (LNCR): Provides oxygen and other respiratory therapy services to home health care market in the United States. Market cap of $1.90B. PEG at 0.69. RSI(14) at 32.46. Offers a good dividend, and appears to have good liquidity to back it up--dividend yield at 3.93%, current ratio at 2.25, and quick ratio at 2.16. The stock has performed poorly over the last month, losing 12.43%.

7. Health Management Associates Inc. (HMA): Engages in the operation of general acute care hospitals and other health care facilities in non-urban communities in the United States. Market cap of $1.88B. PEG at 0.84. RSI(14) at 38.38. This is a risky stock that is significantly more volatile than the overall market (beta = 2.17). The stock has gained 7.26% over the last year.

8. Community Health Systems, Inc. (CYH): Provides healthcare services through the operation of hospitals in the United States. Market cap of $1.72B. PEG at 0.46. RSI(14) at 35.19. The stock is currently stuck in a downtrend, trading 9.3% below its SMA20, 22.39% below its SMA50, and 43% below its SMA200. The stock has performed poorly over the last month, losing 17.2%.

9. Masimo Corporation (MASI): Develops, manufactures, and markets noninvasive patient monitoring products worldwide. Market cap of $1.38B. PEG at 0.98. RSI(14) at 37.84. The stock is a short squeeze candidate, with a short float at 10.88% (equivalent to 9.67 days of average volume). The stock has lost 6.16% over the last year.

10. WuXi PharmaTech (Cayman) Inc. (WX): Engages in providing laboratory and manufacturing services to support research and development for pharmaceutical, biotechnology, and medical device companies. Market cap of $914.09M. PEG at 0.72. RSI(14) at 39.63. The stock is currently stuck in a downtrend, trading 5.76% below its SMA20, 18.07% below its SMA50, and 24.88% below its SMA200. The stock has had a couple of great days, gaining 7.67% over the last week.

11. ZOLL Medical Corp. (ZOLL): Develops, manufactures, and markets resuscitation devices and related software solutions worldwide. Market cap of $908.63M. PEG at 0.88. RSI(14) at 35.94. The stock is currently stuck in a downtrend, trading 7.05% below its SMA20, 23.64% below its SMA50, and 16.47% below its SMA200. The stock has performed poorly over the last month, losing 33.14%.

12. NuVasive, Inc. (NUVA): Engages in the design, development, and marketing of minimally disruptive surgical products and procedures for the spine. Market cap of $870.40M. PEG at 0.65. RSI(14) at 34.47. The stock is a short squeeze candidate, with a short float at 16.97% (equivalent to 6.34 days of average volume). The stock is currently stuck in a downtrend, trading 6.09% below its SMA20, 23.73% below its SMA50, and 24.34% below its SMA200.

13. Molina Healthcare Inc. (MOH): Provides Medicaid-related solutions to meet the health care needs of low-income families and individuals, as well as assists state agencies in their administration of the Medicaid program. Market cap of $819.12M. PEG at 0.61. RSI(14) at 36.17. Might be undervalued at current levels, with a PEG ratio at 0.61, and P/FCF ratio at 4.34. The stock has lost 1.82% over the last year.

14. Greatbatch, Inc. (GB): Provides technology solutions for medical and industrial applications. Market cap of $489.71M. PEG at 0.96. RSI(14) at 37.68. The stock is a short squeeze candidate, with a short float at 8.22% (equivalent to 12.39 days of average volume). The stock has lost 5.81% over the last year.

15. The Ensign Group, Inc. (ENSG): Provides nursing and rehabilitative care services in California, Arizona, Texas, Washington, Utah, Colorado, and Idaho. Market cap of $454.22M. PEG at 0.73. RSI(14) at 37.78. The stock is a short squeeze candidate, with a short float at 6.97% (equivalent to 6. days of average volume). The stock has gained 22.18% over the last year.

16. National Healthcare Corp. (NHC): Operates and manages long-term health care centers, and associated assisted living and independent living centers in the United States. Market cap of $450.30M. PEG at 0.7. RSI(14) at 34.54. Offers a good dividend, and appears to have good liquidity to back it up--dividend yield at 3.69%, current ratio at 1.65, and quick ratio at 1.61. The stock is a short squeeze candidate, with a short float at 5.22% (equivalent to 12.62 days of average volume). The stock has performed poorly over the last month, losing 13.86%.

17. Amedisys Inc. (AMED): Provides home health and hospice services including practical nursing services and physical and occupational therapy. Market cap of $449.73M. PEG at 0.43. RSI(14) at 27.76. The stock is a short squeeze candidate, with a short float at 13.82% (equivalent to 7.39 days of average volume). The stock is currently stuck in a downtrend, trading 8.54% below its SMA20, 31.93% below its SMA50, and 49.77% below its SMA200. The stock has performed poorly over the last month, losing 23.99%.

18. Sunrise Senior Living Inc. (SRZ): Provides senior living services in the United States, Canada, the United Kingdom, and Germany. Market cap of $383.24M. PEG at 0.66. RSI(14) at 38.18. The stock is a short squeeze candidate, with a short float at 11.38% (equivalent to 6.53 days of average volume). The stock is currently stuck in a downtrend, trading 5.32% below its SMA20, 22.44% below its SMA50, and 24.42% below its SMA200. The stock has performed poorly over the last month, losing 13.75%.

19. LHC Group, Inc. (LHCG): Provides post-acute healthcare services primarily to Medicare beneficiaries in rural markets in the United States. Market cap of $344.23M. PEG at 0.59. RSI(14) at 37. The stock is a short squeeze candidate, with a short float at 10.09% (equivalent to 7.28 days of average volume). The stock has performed poorly over the last month, losing 12.72%.

20. Neurocrine Biosciences Inc. (NBIX): Engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. Market cap of $320.94M. PEG at 0.44. RSI(14) at 34.57. The stock is currently stuck in a downtrend, trading 5.29% below its SMA20, 20.45% below its SMA50, and 23.24% below its SMA200. The stock has performed poorly over the last month, losing 13.15%.

21. Conceptus, Inc. (CPTS): Designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and Europe. Market cap of $313.96M. PEG at 0.23. RSI(14) at 37.97. The stock is a short squeeze candidate, with a short float at 7.32% (equivalent to 6.37 days of average volume). The stock is currently stuck in a downtrend, trading 7.42% below its SMA20, 11.75% below its SMA50, and 24.22% below its SMA200. The stock has lost 28.06% over the last year.

22. Sun Healthcare Group Inc. (SUNH): Provides health care services primarily for senior population in the United States. Market cap of $293.96M. PEG at 0.43. RSI(14) at 38.14. The stock has had a good month, gaining 19.09%.

23. SciClone Pharmaceuticals, Inc. (SCLN): Engages in the development and commercialization of novel therapeutics for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in the People's Republic of China and internationally. Market cap of $247.28M. PEG at 0.66. RSI(14) at 31.95. The stock is a short squeeze candidate, with a short float at 5.82% (equivalent to 6. days of average volume). The stock is currently stuck in a downtrend, trading 13.15% below its SMA20, 26.31% below its SMA50, and 11.64% below its SMA200.

24. eResearchTechnology, Inc. (ERT): Provides technological services and medical devices in North America and the United Kingdom. Market cap of $236.30M. PEG at 0.89. RSI(14) at 38.69. The stock is currently stuck in a downtrend, trading 6.1% below its SMA20, 19.29% below its SMA50, and 25.22% below its SMA200. The stock has performed poorly over the last month, losing 13.67%.

25. Pernix Therapeutics Holdings, Inc. (PTX): Engages in the development, marketing, and sale of branded and generic pharmaceutical products primarily for the pediatric market. Market cap of $211.85M. PEG at 0.61. RSI(14) at 39.17. The stock is currently stuck in a downtrend, trading 7.08% below its SMA20, 10.92% below its SMA50, and 16.41% below its SMA200.

*Data sourced from Finviz.

Source: 25 Oversold, Undervalued Healthcare Stocks